Literature DB >> 8546197

Antigen-presenting cell engineering. The molecular toolbox.

M L Tykocinski1, D R Kaplan, M E Medof.   

Abstract

Mesh：

Year:  1996        PMID： 8546197      PMCID： PMC1861622     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  171 in total

Review 1.  Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance.

Authors:  V A Boussiotis; J G Gribben; G J Freeman; L M Nadler
Journal:  Curr Opin Immunol       Date:  1994-10       Impact factor: 7.486

Review 2.  Tumor immunotherapy: the tumor cell as an antigen-presenting cell.

Authors:  S Ostrand-Rosenberg
Journal:  Curr Opin Immunol       Date:  1994-10       Impact factor: 7.486

3.  A simple mathematical model for the functional peptide/MHC/TCR interactions.

Authors:  G Eberl; M A Roggero; G Corradin
Journal:  J Immunol       Date:  1995-01-01       Impact factor: 5.422

Review 4.  Cytokines and cancer: experimental systems.

Authors:  T Blankenstein; D A Rowley; H Schreiber
Journal:  Curr Opin Immunol       Date:  1991-10       Impact factor: 7.486

Review 5.  Apoptosis, oncosis, and necrosis. An overview of cell death.

Authors:  G Majno; I Joris
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

6.  The insulin-like growth factor I receptor: a key to tumor growth?

Authors:  R Baserga
Journal:  Cancer Res       Date:  1995-01-15       Impact factor: 12.701

7.  Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide.

Authors:  G E Peoples; P S Goedegebuure; R Smith; D C Linehan; I Yoshino; T J Eberlein
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

8.  Ligand-induced adhesion to activated endothelium and to vascular cell adhesion molecule-1 in lymphocytes transfected with the N-formyl peptide receptor.

Authors:  S Honda; J J Campbell; D P Andrew; B Engelhardt; B A Butcher; R A Warnock; R D Ye; E C Butcher
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

9.  Purified GPI-anchored CD4DAF as a receptor for HIV-mediated gene transfer.

Authors:  R A Brodsky; S M Jane; E F Vanin; H Mitsuya; T R Peters; T Shimada; M E Medof; A W Nienhuis
Journal:  Hum Gene Ther       Date:  1994-10       Impact factor: 5.695

10.  Cells expressing a major histocompatibility complex class I molecule with a single covalently bound peptide are highly immunogenic.

Authors:  E Mottez; P Langlade-Demoyen; H Gournier; F Martinon; J Maryanski; P Kourilsky; J P Abastado
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307
View more
  5 in total

1.  Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells.

Authors:  F O Nestle; G Burg; J Fäh; T Wrone-Smith; B J Nickoloff
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

Review 2.  Molecular analysis of premalignant and carcinoma in situ lesions of the human breast.

Authors:  P S Steeg; S E Clare; J A Lawrence; Q Zhou
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

Review 3.  Killer artificial antigen-presenting cells: the synthetic embodiment of a 'guided missile'.

Authors:  Christian Schütz; Mathias Oelke; Jonathan P Schneck; Andreas Mackensen; Martin Fleck
Journal:  Immunotherapy       Date:  2010-07       Impact factor: 4.196

Review 4.  Targeting the B7 family of co-stimulatory molecules: successes and challenges.

Authors:  Joseph R Podojil; Stephen D Miller
Journal:  BioDrugs       Date:  2013-02       Impact factor: 5.807

Review 5.  New designs for cancer vaccine and artificial veto cells: an emerging palette of protein paints.

Authors:  Mark L Tykocinski; Aoshuang Chen; Jui-Han Huang; Matthew C Weber; Guoxing Zheng
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.